TM4SF1 is also highly expressed in other cancer types, including prostate (Allioli et al., 2011), ovarian (Gao et al., 2019), glioma (Wang et al., 2015), colorectal (Park et al., 2017), liver (Zhu et al., 2021), thyroid (Lee et al., 2019), lung (Ma et al., 2018), pancreatic (Cao et al., 2016), and breast cancers (Tu et al., 2012; Xing et al., 2017; Fan et al., 2019). Here, TM4SF1 is linked to breast cancer.